Urinary Sodium Excretion Measures and Health Outcomes
Feng J. He,Monique Tan,Graham A. MacGregor
DOI: https://doi.org/10.1016/s0140-6736(19)30021-2
2019-01-01
Abstract:We were disappointed to see yet another re-analysis, by Andrew Mente and colleagues (Aug 11, 2018, p 496),1Mente A O'Donnell M Rangarajan S et al.Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study.Lancet. 2018; 392: 496-506Summary Full Text Full Text PDF PubMed Scopus (184) Google Scholar of the Prospective Urban Rural Epidemiology (PURE) study on salt, despite its many flaws. Mente and colleagues claimed that reducing salt is only justified in countries where intake is greater than 12·5 g/day, challenging WHO's recommendation to reduce salt intake to less than 5 g/day. These conclusions are not valid because of the inaccurate estimation of salt intake from spot urine using the Kawasaki formula, which has been repeatedly shown to be unreliable and systematically biased.2He FJ Campbell NRC Ma Y MacGregor GA Cogswell ME Cook NR Errors in estimating usual sodium intake by the Kawasaki formula alter its relationship with mortality: implications for public health.Int J Epidemiol. 2018; 47: 1784-1795Crossref PubMed Scopus (63) Google Scholar, 3Cogswell ME Mugavero K Bowman BA Frieden TR Dietary sodium and cardiovascular disease risk— measurement matters.N Engl J Med. 2016; 375: 580-586Crossref PubMed Scopus (134) Google Scholar Even when salt intake is measured on several occasions, allowing for the large day-to-day variation in salt intake, and using 24 h urine collections (ie, the most accurate way of assessing salt intake), this measurement does not necessarily reflect the potential changes that occurred throughout the 8·1 years of follow-up, particularly as many countries were reducing salt intake during the period of the PURE studies.4Trieu K Neal B Hawkes C et al.Salt reduction initiatives around the world – a systematic review of progress towards the global target.PLoS One. 2015; 10: e0130247Crossref PubMed Scopus (287) Google Scholar In studies in which 24 h urine was collected several times, a direct linear association with cardiovascular events and total mortality was evident,2He FJ Campbell NRC Ma Y MacGregor GA Cogswell ME Cook NR Errors in estimating usual sodium intake by the Kawasaki formula alter its relationship with mortality: implications for public health.Int J Epidemiol. 2018; 47: 1784-1795Crossref PubMed Scopus (63) Google Scholar, 5Olde Engberink RHG van den Hoek TC van Noordenne ND van den Born B-JH Peters-Sengers H Vogt L Use of a single baseline versus multiyear 24-hour urine collection for estimation of long-term sodium intake and associated cardiovascular and renal risk.Circulation. 2017; 136: 917-926Crossref PubMed Scopus (73) Google Scholar down to an intake of 3 g/day.2He FJ Campbell NRC Ma Y MacGregor GA Cogswell ME Cook NR Errors in estimating usual sodium intake by the Kawasaki formula alter its relationship with mortality: implications for public health.Int J Epidemiol. 2018; 47: 1784-1795Crossref PubMed Scopus (63) Google Scholar Additionally, upon replacement of accurately measured 24 h urinary sodium excretions with estimates derived from the Kawasaki formula, the linear association was altered and appeared to be J-shaped (see figure 4 in our Article),2He FJ Campbell NRC Ma Y MacGregor GA Cogswell ME Cook NR Errors in estimating usual sodium intake by the Kawasaki formula alter its relationship with mortality: implications for public health.Int J Epidemiol. 2018; 47: 1784-1795Crossref PubMed Scopus (63) Google Scholar again showing the major problems of using a biased estimation of salt intake in the PURE studies. Mente and colleagues1Mente A O'Donnell M Rangarajan S et al.Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study.Lancet. 2018; 392: 496-506Summary Full Text Full Text PDF PubMed Scopus (184) Google Scholar do not put into perspective the totality of the evidence for the effects of salt intake on cardiovascular disease, as judged by epidemiological, migration, population-based intervention, treatment, animal, and genetic studies, as well as outcome trials. This evidence is much more robust than other dietary measures. Therefore, the findings of the PURE studies should be taken with a pinch of salt—but do not eat it; throw it over your left shoulder to ward off the devil. FJH is a member of Consensus Action on Salt and Health (CASH) and World Action on Salt and Health (WASH). Both CASH and WASH are non-profit charitable organisations and FJH does not receive financial support from either organisation. GAM is Chairman of Blood Pressure UK (BPUK), CASH, WASH, and Action on Sugar (AoS). BPUK and AoS are also non-profit charitable organisations and GAM does not receive financial support from any of these organisations. MT declares no competing interests. Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort studySodium intake was associated with cardiovascular disease and strokes only in communities where mean intake was greater than 5 g/day. A strategy of sodium reduction in these communities and countries but not in others might be appropriate. Full-Text PDF Urinary sodium excretion measures and health outcomesThe US recommendation for sodium intake is less than 2·3 g/day for healthy individuals and less than 1·5 g/day for those at risk of cardiovascular disease.1 In 2013, the US National Academy of Medicine concluded that insufficient evidence was available to support such a recommendation. The question remains of whether existing data provide compelling evidence that these guidelines are feasible and will confer health benefit. The recent report by Mente and colleagues2 adds to the literature challenging the long-standing presumption of health benefits. Full-Text PDF Urinary sodium excretion measures and health outcomesFranz Messerli and colleagues1 discuss the Article by Andrew Mente and colleagues2 about salt, blood pressure, and cardiovascular outcomes, asking the rhetorical question of whether it is “bad science”. We posit that the 50-year-old controversy on salt and cardiovascular morbidity (uniform benefit of salt reduction versus harmful effects for some at very low salt intake—ie, the J curve association) is an issue of no accurate data on salt intake instead. Full-Text PDF Urinary sodium excretion measures and health outcomesIn their analysis of the Prospective Urban Rural Epidemiology (PURE) study, Andrew Mente and colleagues1 investigated the association between sodium intake and cardiovascular disease. However, the authors seem to have ignored new evidence showing that sodium excretion might not necessarily reflect sodium intake. Full-Text PDF Urinary sodium excretion measures and health outcomes – Authors' reply24 h urine collection is a reference method, rather than the gold standard for measuring sodium intake. A key test of whether different measures of sodium intake are valid is to compare each measure with an independent biomarker, such as blood pressure (BP)—an association upon which current recommendations for reducing sodium intake are based. Large epidemiological studies with 24 h urine collections have shown a weak1 or no2,3 association between 24 h sodium excretion and BP, but several studies that use early-morning fasting urine to estimate sodium intake (with adequate methods—namely the appropriate formula for fasting urine and correct timing of fasting urine collection immediately after a proper 24 h urine collection) show stronger associations with BP than 24 h urine collections,4,5 similar to the 2·42 mm Hg reduction in systolic BP per 1 g lowering of sodium consumption observed in randomised trials. Full-Text PDF